Sfoglia per AUTORE
ERMANI M
Collezione ASL Cuneo 2
Items : 2
Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications. in The oncologist / Oncologist. 2017 Apr;22(4):432-437. doi: 10.1634/theoncologist.2016-0254. Epub 2017 Mar 8.
2017
ASL Cuneo 2
ASL Cuneo 2
Pia Foschini M; Fioravanti A; Talacchi A; Servadei F; Volpin L; Sturiale C; Silini EM; Lanza G; Zunarelli E; Ghimenton C; Danieli D; De Biase D; Paccapelo A; Tallini G; Brandes AA; Franceschi E; Bartolini S; Pession A; Ermani M;
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2009 Sep;64(4):769-75. doi: 10.1007/s00280-009-0926-8. Epub 2009 Jan 24.
2009
ASL Cuneo 2
ASL Cuneo 2
Santoro A; Faedi M; Amistà P; Blatt V; Franceschi E; Tosoni A; Brandes AA; Gardiman M; Labianca R; Bianchini C; Ermani M; Reni M;